Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 11, 2022

Poorer Sense of Smell Can Be Evident Even in Early Stages of MS, Study Says

  • Multiple Sclerosis (MS) Symptoms
    /
by Jose Marques Lopes PhD  People with multiple sclerosis (MS) can indeed have a poorer-than-usual sense of smell, with problems possibly starting…
Multiple Sclerosis (MS) Symptoms

April 11, 2022

Smell Test Might Help Predict if MS Treatments Are Working

  • Additional MS resource sites
    /
  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
  A measure of the nose’s sensitivity to smell could be used to detect whether treatments for relapsing multiple sclerosis (MS) are…
Additional MS resource sites

April 6, 2022

Understanding Uhthoff’s Phenomenon: Overheating with MS

  • Multiple Sclerosis (MS) Symptoms
    /
 When multiple sclerosis (MS) symptoms worsen from overheating, it’s called Uhthoff’s phenomenon. Learn more about prevention and treatment. Some people…
Multiple Sclerosis (MS) Symptoms

April 4, 2022

Learn to recognize and manage the possible symptoms of MS, which range from mild to severe.

  • Multiple Sclerosis (MS) Symptoms
    /
  • Symptoms
    /
More common symptoms Less common symptoms Secondary symptoms and the impact of disease Additional resources Click above links to read…
Multiple Sclerosis (MS) Symptoms

April 4, 2022

New Data for Genentech’s Ocrevus (Ocrelizumab) Show Benefit in Disability Progression and Cognitive Decline in Both Secondary Progressive and Primary Progressive Multiple Sclerosis

  • MS Drug Therapies
    /
  • Ocrevus
    /
  75% of patients with secondary progressive multiple sclerosis (SPMS) and primary progressive MS (PPMS) achieved no evidence of progression…
MS Drug Therapies

March 30, 2022

Latest updates for diagnosis and management of NMOSD

  • NMO (NMOSD/Devics)
    /
  In this enduring touchSATELLITE SYMPOSIUM (#ACTRIMS22), Prof. Sean Pittock, Dr Amy Kunchok, and Prof. Dean Wingerchuk share their insights…
NMO (NMOSD/Devics)

March 29, 2022

About BAFIERTAM™ (monomethyl fumarate) treatment, for Multiple Sclerosis

  • MS Drug Therapies
    /
Banner Life Sciences Announces BAFIERTAM, a Novel Oral Fumarate Treatment for Relapsing Forms of Multiple Sclerosis, is available in the…
MS Drug Therapies

March 29, 2022

Survey Alert: What Health Issues are the Highest Research Priorities for Women Living with MS?

  • Misc. MS Related
    /
 March 29, 2022 Recent research pinpointed significant knowledge gaps in the extent to which women’s health issues have been studied…
Misc. MS Related

March 22, 2022

Myelin Repair, Progressive MS, Exercise, and Other Research News

  • MRI
    /
  • MS Diet & Nutrition
    /
  • MS Genetic Research
    /
  • Multiple Sclerosis
    /
  • Myelin Repair
    /
  • National MS Society Related
    /
 October 22, 2021 Myelin repair strategies, progressive MS, exercise, and other promising avenues took center stage at the virtual European…
MRI

March 18, 2022

3D Showing of Mayzent Binding to Receptor Could Advance Treatments

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 by Steve Bryson PhD | March 18, 2022 For the first time, researchers have brought to light the precise three-dimensional structure of Mayzent (siponimod) as…
MS Drug Therapies

Categories

Latest Blog Posts